Business · 14/01/2000

FDA Announces Amendment to Peripheral and Central Nervous System Drugs Advisory Committee Meeting

The FDA is canceling a session of the Peripheral and Central Nervous System Drugs Advisory Committee meeting originally scheduled for January 27, 2000, while the rest of the meeting remains unchanged.